Zur Kurzanzeige

dc.contributor.authorQueiro, Rubén
dc.contributor.authorSeoane-Mato, Daniel
dc.contributor.authorLaiz, Ana
dc.contributor.authorGalíndez Agirregoikoa, Eva
dc.contributor.authorMontilla Morales, Carlos Alberto 
dc.contributor.authorHye-Sang, Park
dc.contributor.authorPinto-Tasende, José A.
dc.contributor.authorBethencourt Baute, Juan J.
dc.contributor.authorJoven Ibáñez, Beatriz
dc.contributor.authorToniolo, Elide
dc.contributor.authorRamírez, Julio
dc.contributor.authorSerrano García, Ana
dc.date.accessioned2025-01-20T14:17:23Z
dc.date.available2025-01-20T14:17:23Z
dc.date.issued2022-06-24
dc.identifier.citationQueiro, R., Seoane-Mato, D., Laiz, A., Agirregoikoa, E. G., Montilla, C., Park, H.-S., Pinto-Tasende, J. A., Bethencourt Baute, J. J., Ibáñez, B. J., Toniolo, E., Ramírez, J., & García, A. S. (2022). Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. Arthritis research & therapy, 24(1), 153. https://doi.org/10.1186/S13075-022-02838-2es_ES
dc.identifier.urihttp://hdl.handle.net/10366/162055
dc.descriptionArticle number: 153 (2022)es_ES
dc.description.abstract[EN]Very few data are available on predictors of minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis (PsA). Such data are crucial, since the therapeutic measures used to change the adverse course of PsA are more likely to succeed if we intervene early. In the present study, we used predictive models based on machine learning to detect variables associated with achieving MDA in patients with recent-onset PsA. We performed a multicenter observational prospective study (2-year follow-up, regular annual visits). The study population comprised patients aged ≥18 years who fulfilled the CASPAR criteria and less than 2 years since the onset of symptoms. The dataset contained data for the independent variables from the baseline visit and from follow-up visit number 1. These were matched with the outcome measures from follow-up visits 1 and 2, respectively. We trained a random forest-type machine learning algorithm to analyze the association between the outcome measure and the variables selected in the bivariate analysis. In order to understand how the model uses the variables to make its predictions, we applied the SHAP technique. We used a confusion matrix to visualize the performance of the model. The sample comprised 158 patients. 55.5% and 58.3% of the patients had MDA at the first and second follow-up visit, respectively. In our model, the variables with the greatest predictive ability were global pain, impact of the disease (PsAID), patient global assessment of disease, and physical function (HAQ-Disability Index). The percentage of hits in the confusion matrix was 85.94%. A key objective in the management of PsA should be control of pain, which is not always associated with inflammatory burden, and the establishment of measures to better control the various domains of PsA.es_ES
dc.description.sponsorshipEste trabajo fue apoyado por AbbVie, que no tuvo ningún rol en el diseño, recopilación de datos, análisis de datos, interpretación o redacción de este manuscrito.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Centrales_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectRecent‐onset psoriatic arthritises_ES
dc.subjectMinimal disease activityes_ES
dc.subjectPredictive modeles_ES
dc.subjectMachine learninges_ES
dc.subject.meshArthritis *
dc.titleMinimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learninges_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://arthritis-research.biomedcentral.com/articles/10.1186/s13075-022-02838-2es_ES
dc.subject.unesco3205 Medicina Internaes_ES
dc.identifier.doi10.1186/S13075-022-02838-2
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1478-6362
dc.journal.titleArthritis Research & Therapyes_ES
dc.volume.number24es_ES
dc.issue.number1es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsartritis *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional